Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/81793
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Low adoption of pharmacogenetic testing: an exploration and explanation of the reasons in Australia
Author: Corkindale, D.
Ward, H.
McKinnon, R.
Citation: Personalized Medicine, 2007; 4(2):191-199
Publisher: Future Medicine
Issue Date: 2007
ISSN: 1741-0541
1744-828X
Statement of
Responsibility: 
David Corkindale, Helena Ward & Ross McKinnon
Abstract: The research reported here sought to identify and illuminate the reasons for the low adoption of pharmacogenetic tests in Australia. The research initially established possible reasons and propositions drawn from previous studies and surveys on the problem in Europe and the literature on the adoption of innovations. A small-scale exploratory, qualitative study was undertaken in one state in Australia; clinicians and other stake-holders were interviewed about their use of or support for pharmacogenetic tests. The expected, quite extensive individual factors known to influence adoption and rejection of innovations were found to be present in the situations covered. The reasons for nonadoption that were found in previous surveys were also supported. Some other, possibly critical, reasons were also identified. The implications from this initial exploration are discussed and the prospects for the increased use of the tests proposed.
Keywords: Abacovir; Adoption of innovations; Azathioprine; HER2; Perhexiline; Pharmacogenetic tests; Reasons for nonadoption; TPMT; Warfarin
Rights: © 2007 Future Medicine Ltd.
RMID: 0030000217
DOI: 10.2217/17410541.4.2.191
Appears in Collections:Medical Education Unit publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.